Kimberly-Clark (NYSE:KMB) PT Raised to $125.00

Kimberly-Clark (NYSE:KMB) had its price target raised by equities researchers at Citigroup from $111.00 to $125.00 in a research report issued on Wednesday, Benzinga reports. The brokerage currently has a “sell” rating on the stock. Citigroup’s price objective suggests a potential downside of 8.38% from the stock’s previous close.

Several other research firms have also commented on KMB. Evercore ISI raised Kimberly-Clark from an “in-line” rating to an “outperform” rating and lifted their price target for the stock from $133.00 to $150.00 in a research report on Thursday, March 28th. JPMorgan Chase & Co. lifted their price target on Kimberly-Clark from $115.00 to $123.00 and gave the stock an “underweight” rating in a research report on Wednesday. Deutsche Bank Aktiengesellschaft lifted their price target on Kimberly-Clark from $127.00 to $132.00 and gave the stock a “hold” rating in a research report on Thursday, March 28th. Royal Bank of Canada boosted their target price on Kimberly-Clark from $123.00 to $126.00 and gave the company a “sector perform” rating in a report on Wednesday. Finally, Barclays boosted their target price on Kimberly-Clark from $124.00 to $132.00 and gave the company an “equal weight” rating in a report on Friday, April 12th. Three investment analysts have rated the stock with a sell rating, seven have given a hold rating and four have assigned a buy rating to the company. According to MarketBeat, Kimberly-Clark presently has an average rating of “Hold” and a consensus target price of $135.50.

Kimberly-Clark Price Performance

KMB stock opened at $136.43 on Wednesday. The business has a 50 day moving average price of $125.53 and a 200 day moving average price of $122.75. The stock has a market cap of $45.96 billion, a price-to-earnings ratio of 25.08, a PEG ratio of 4.05 and a beta of 0.40. Kimberly-Clark has a fifty-two week low of $116.32 and a fifty-two week high of $147.09. The company has a quick ratio of 0.54, a current ratio of 0.81 and a debt-to-equity ratio of 6.05.

Kimberly-Clark (NYSE:KMB) last released its quarterly earnings results on Tuesday, April 23rd. The company reported $2.01 EPS for the quarter, topping the consensus estimate of $1.61 by $0.40. The company had revenue of $5.15 billion for the quarter, compared to analyst estimates of $5.08 billion. Kimberly-Clark had a return on equity of 250.28% and a net margin of 9.05%. The firm’s revenue was down .9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.67 earnings per share. Equities research analysts anticipate that Kimberly-Clark will post 6.84 earnings per share for the current fiscal year.

Insider Buying and Selling

In other Kimberly-Clark news, Director Mark T. Smucker acquired 827 shares of the company’s stock in a transaction that occurred on Monday, January 29th. The shares were purchased at an average price of $120.98 per share, with a total value of $100,050.46. Following the completion of the acquisition, the director now directly owns 827 shares of the company’s stock, valued at approximately $100,050.46. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. In other Kimberly-Clark news, insider Paula Ramos sold 10,178 shares of the business’s stock in a transaction on Wednesday, April 24th. The stock was sold at an average price of $137.17, for a total transaction of $1,396,116.26. Following the sale, the insider now directly owns 795 shares in the company, valued at $109,050.15. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Mark T. Smucker bought 827 shares of the firm’s stock in a transaction on Monday, January 29th. The shares were purchased at an average price of $120.98 per share, for a total transaction of $100,050.46. Following the completion of the transaction, the director now owns 827 shares of the company’s stock, valued at approximately $100,050.46. The disclosure for this purchase can be found here. 0.62% of the stock is currently owned by corporate insiders.

Institutional Trading of Kimberly-Clark

A number of institutional investors have recently bought and sold shares of KMB. OFI Invest Asset Management purchased a new stake in Kimberly-Clark during the third quarter worth $25,000. Rise Advisors LLC boosted its position in Kimberly-Clark by 926.3% during the first quarter. Rise Advisors LLC now owns 195 shares of the company’s stock worth $25,000 after purchasing an additional 176 shares in the last quarter. Cranbrook Wealth Management LLC boosted its position in Kimberly-Clark by 90.9% during the fourth quarter. Cranbrook Wealth Management LLC now owns 210 shares of the company’s stock worth $26,000 after purchasing an additional 100 shares in the last quarter. Accordant Advisory Group Inc purchased a new stake in shares of Kimberly-Clark in the first quarter valued at $27,000. Finally, Centerpoint Advisors LLC lifted its position in shares of Kimberly-Clark by 175.0% in the third quarter. Centerpoint Advisors LLC now owns 275 shares of the company’s stock valued at $33,000 after acquiring an additional 175 shares in the last quarter. 76.29% of the stock is currently owned by hedge funds and other institutional investors.

Kimberly-Clark Company Profile

Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care and consumer tissue products in the United States. It operates through three segments: Personal Care, Consumer Tissue, and K-C Professional. The company's Personal Care segment offers disposable diapers, training and youth pants, swimpants, baby wipes, feminine and incontinence care products, reusable underwear, and other related products under the Huggies, Pull-Ups, Little Swimmers, GoodNites, DryNites, Sweety, Kotex, U by Kotex, Intimus, Thinx, Poise, Depend, Plenitud, Softex, and other brand names.